Omega Funds

United States · Venture Capital & Private Equity

Omega Funds is a Boston-based venture capital and private equity firm founded in 2004. The firm specializes in investing in life sciences, biotechnology, healthcare, and medical device companies. It focuses on early-stage to growth-stage investments, targeting companies that develop innovative therapies and technologies to address urgent medical needs. The firm recently closed an oversubscribed $647 million Fund VIII in 2025, showcasing its strong fundraising capabilities. Omega Funds provides capital and strategic guidance to visionary entrepreneurs and disruptive technologies, helping portfolio companies accelerate growth and commercialization. Its investment strategy emphasizes supporting high-growth life sciences companies that aim to transform patient care. Omega Funds primarily serves early-stage and growth-stage biotech and healthcare startups seeking venture capital, as well as institutional investors interested in funding innovative biotech ventures. The firm is recognized for its significant contributions to advancing healthcare startups and fostering innovation in the life sciences sector.